These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10952473)

  • 1. Oral vasoactive medication in intermittent claudication: utile or futile?
    De Backer TL; Vander Stichele RH; Warie HH; Bogaert MG
    Eur J Clin Pharmacol; 2000 Jun; 56(3):199-206. PubMed ID: 10952473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buflomedil for intermittent claudication.
    De Backer TL; Vander Stichele RH; Bogaert MG
    Cochrane Database Syst Rev; 2001; (1):CD000988. PubMed ID: 11279700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
    Squires H; Simpson E; Meng Y; Harnan S; Stevens J; Wong R; Thomas S; Michaels J; Stansby G
    Health Technol Assess; 2011 Dec; 15(40):1-210. PubMed ID: 22142554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buflomedil for intermittent claudication.
    de Backer TL; Bogaert M; Vander Stichele R
    Cochrane Database Syst Rev; 2007 Oct; (4):CD000988. PubMed ID: 17943749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
    Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
    Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buflomedil for intermittent claudication.
    de Backer TL; Bogaert M; Vander Stichele R
    Cochrane Database Syst Rev; 2008 Jan; (1):CD000988. PubMed ID: 18253982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline for intermittent claudication.
    Salhiyyah K; Forster R; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
    Cochrane Database Syst Rev; 2015 Sep; 9(9):CD005262. PubMed ID: 26417854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buflomedil for intermittent claudication.
    de Backer TL; Vander Stichele R
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD000988. PubMed ID: 23543509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naftidrofuryl for intermittent claudication.
    De Backer TL; Vander Stichele R; Lehert P; Van Bortel L
    Cochrane Database Syst Rev; 2008 Apr; (2):CD001368. PubMed ID: 18425872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.
    De Backer T; Vander Stichele R; Lehert P; Van Bortel L
    BMJ; 2009 Mar; 338():b603. PubMed ID: 19276131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naftidrofuryl for intermittent claudication.
    de Backer TL; Vander Stichele R; Lehert P; Van Bortel L
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD001368. PubMed ID: 23235580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline for intermittent claudication.
    Salhiyyah K; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005262. PubMed ID: 22258961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication.
    Rosas G; Cerdeyra C; Lucas MA; Parano JR; Villa JJ
    Angiology; 1981 May; 32(5):291-7. PubMed ID: 7235299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.
    Girolami B; Bernardi E; Prins MH; Ten Cate JW; Hettiarachchi R; Prandoni P; Girolami A; Büller HR
    Arch Intern Med; 1999 Feb; 159(4):337-45. PubMed ID: 10030306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silence of the limbs pharmacological symptomatic treatment of intermittent claudication.
    De Backer T; Vander Stichele R; De Buyzere M; De Backer G; Van Bortel L
    Curr Vasc Pharmacol; 2010 May; 8(3):383-7. PubMed ID: 19485897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicriteria decision analysis for determining drug therapy for intermittent claudication.
    Pérez Encinas M; Fernández MA; Martín ML; Calvo MV; Gómez-Alonso A; Dominguez-Gil A; Lozano F
    Methods Find Exp Clin Pharmacol; 1998 Jun; 20(5):425-31. PubMed ID: 9701781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication.
    Cosmi B; Conti E; Coccheri S
    Cochrane Database Syst Rev; 2001; (3):CD001999. PubMed ID: 11687006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
    Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
    Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.